Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
GH RESEARCH PLC
About GHRS
GH Research PLC is a clinical-stage biopharmaceutical company. The Company is focusing on developing its novel and proprietary mebufotenin therapies for the treatment of patients with treatment-resistant depression (TRD). Its portfolio includes GH001, its proprietary inhalable mebufotenin product candidate and GH002, its proprietary intravenous mebufotenin product candidate. GH001 is delivered via a vaporization device produced by a third party, and the Company is developing a proprietary aerosol delivery device which is in clinical investigation in Europe. GH001 completed two Phase 1 clinical trials in healthy volunteers, a Phase 1/2 trial in TRD and two Phase 2a proof-of-concept trials. GH002 Completed a randomized, double-blind, placebo-controlled, dose-ranging clinical pharmacology trial of GH002 in healthy volunteers, and it is developing GH002 within its focus area of psychiatric and neurological disorders.
Find out what a historical investment in GH RESEARCH PLC would be worth today using our GHRS stock calculator.
Market Capitalisation
$1.52B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
201.15K
High today
$22.36
Low today
$20.69
Open price
$21.97
52-week high
$24.66
52-week low
$9.52
Ready to start your investing journey with Stake?
Open an accountHow do I buy GHRS shares in Australia?
Buying GHRS shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in GH RESEARCH PLC in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in GHRS
What is the ticker symbol of GH RESEARCH PLC?
The ticker symbol for GH RESEARCH PLC is GHRS.
How much is one share of GHRS?
One share of GHRS is valued at $21.63 as of 16 May 2026.
What is the market capitalisation of GH RESEARCH PLC GHRS?
As of 16 May 2026 GH RESEARCH PLC has a market cap of $1.52B.
What is the 52-week high for GH RESEARCH PLC stock?
The GH RESEARCH PLC 52-week high stock price is $24.66.
What is the 52-week low for GH RESEARCH PLC stock?
The GH RESEARCH PLC 52-week low stock price is $9.52.
Can I buy GHRS shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy GHRS shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in GHRS on Stake
- Buy GHRS from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of GHRS from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
GHRS related stocks